• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸膜内低渗顺铂治疗恶性胸膜间皮瘤:体外实验与临床应用

Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma: in vitro experiments and clinical application.

作者信息

Tagawa Tetsuzo, Yoshino Ichiro, Yamaguchi Masafumi, Osoegawa Atsushi, Kameyama Toshifumi, Fukuyama Seiichi, Kometani Takuro, Maehara Yoshihiko

机构信息

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

出版信息

Surg Today. 2006;36(2):135-9. doi: 10.1007/s00595-005-3132-2.

DOI:10.1007/s00595-005-3132-2
PMID:16440159
Abstract

PURPOSE

We studied the inhibitory effects of hypotonic cisplatin on the growth of malignant pleural mesothelioma (MPM) cell lines in vitro, and assessed the effectiveness of intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy for patients with this tumor.

METHODS

In the in vitro experiments, mesothelioma cell lines were exposed to various concentrations of cisplatin in either saline solution or distilled water for up to 5 min. After 48 h incubation, we calculated the inhibition of cell growth. In the clinical study, five patients with MPM underwent intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy.

RESULTS

The hypotonic cisplatin treatment inhibited cell growth at a significantly greater rate than the isotonic cisplatin treatment. Just 1-5 min exposure to 10 microg/ml of hypotonic cisplatin inhibited growth by more than 80%. Clinically, no recurrence was found in four of the five patients after a median follow-up period of 27 months (range: 16-36 months), although contralateral multiple pulmonary metastases were found in one patient 10 months after surgery.

CONCLUSION

Hypotonic cisplatin treatment is effective against MPM, and should be investigated further.

摘要

目的

我们研究了低渗顺铂对恶性胸膜间皮瘤(MPM)细胞系体外生长的抑制作用,并评估了术中胸膜腔内注入低渗顺铂联合胸膜外全肺切除术治疗该肿瘤患者的有效性。

方法

在体外实验中,将间皮瘤细胞系暴露于不同浓度的顺铂溶液(生理盐水或蒸馏水)中长达5分钟。孵育48小时后,计算细胞生长抑制率。在临床研究中,5例MPM患者接受了术中胸膜腔内注入低渗顺铂联合胸膜外全肺切除术。

结果

低渗顺铂治疗比等渗顺铂治疗对细胞生长的抑制率显著更高。仅1 - 5分钟暴露于10微克/毫升的低渗顺铂中,细胞生长抑制率就超过80%。临床上,5例患者中有4例在中位随访期27个月(范围:16 - 36个月)后未发现复发,尽管有1例患者在术后10个月出现对侧多发性肺转移。

结论

低渗顺铂治疗对MPM有效,应进一步研究。

相似文献

1
Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma: in vitro experiments and clinical application.胸膜内低渗顺铂治疗恶性胸膜间皮瘤:体外实验与临床应用
Surg Today. 2006;36(2):135-9. doi: 10.1007/s00595-005-3132-2.
2
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.胸膜外全肺切除术后术中胸腔内热灌注顺铂并给予药理细胞保护治疗恶性胸膜间皮瘤:一项II期前瞻性研究。
J Thorac Cardiovasc Surg. 2009 Aug;138(2):405-11. doi: 10.1016/j.jtcvs.2009.02.046.
3
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.高热术中胸膜顺铂化疗延长了低危恶性胸膜间皮瘤患者接受手术宏观完全切除术后的复发和生存间隔。
J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-963. doi: 10.1016/j.jtcvs.2012.12.037. Epub 2013 Feb 21.
4
Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.用于研究胸膜内治疗的恶性胸膜间皮瘤局部复发模型
Eur J Cardiothorac Surg. 2007 May;31(5):773-8. doi: 10.1016/j.ejcts.2007.01.047. Epub 2007 Mar 12.
5
[Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].[包括胸膜外全肺切除术在内的恶性胸膜间皮瘤多模式治疗]
Zentralbl Chir. 2008 Jun;133(3):231-7. doi: 10.1055/s-2008-1076790.
6
Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy in patients with lung cancer. In vitro experiments and preliminary clinical results.肺癌患者开胸手术时发现的癌性胸膜炎的低渗顺铂治疗。体外实验及初步临床结果。
J Thorac Cardiovasc Surg. 1993 Jun;105(6):1041-6.
7
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.接受胸膜外全肺切除术的恶性胸膜间皮瘤患者 3 年生存的临床和病理特征。
Eur J Cardiothorac Surg. 2011 Aug;40(2):298-303. doi: 10.1016/j.ejcts.2010.12.024. Epub 2011 Feb 9.
8
A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.一项关于胸膜外肺切除术联合术中腔内顺铂热灌注及氨磷汀细胞保护治疗恶性胸膜间皮瘤的I期研究。
J Thorac Cardiovasc Surg. 2009 Feb;137(2):453-8. doi: 10.1016/j.jtcvs.2008.07.055.
9
Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.恶性胸膜间皮瘤的胸膜外全肺切除术:治疗结果及预后因素
J Thorac Cardiovasc Surg. 2009 Sep;138(3):619-24. doi: 10.1016/j.jtcvs.2008.12.045. Epub 2009 Mar 9.
10
In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.使用胶原凝胶微滴包埋培养药物试验(CD-DST)对恶性胸膜间皮瘤进行体外化学敏感性试验:临床应用的可能性。
Ann Thorac Cardiovasc Surg. 2008 Dec;14(6):355-62.

引用本文的文献

1
Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.临床前研究确定了治疗人类恶性胸膜间皮瘤的新型靶向药理策略。
Br J Pharmacol. 2012 May;166(2):532-53. doi: 10.1111/j.1476-5381.2012.01873.x.
2
Diffuse malignant pleural mesothelioma: a multi-institutional clinicopathological study.弥漫性恶性胸膜间皮瘤:一项多机构临床病理研究。
Surg Today. 2008;38(11):993-8. doi: 10.1007/s00595-008-3776-9. Epub 2008 Oct 29.

本文引用的文献

1
A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical intervention.一项针对胸膜冲洗细胞学阳性的非小细胞肺癌切除患者术中胸膜内注射低渗顺铂治疗的III期试验提前终止:手术干预后癌性胸膜炎的发生率
J Thorac Cardiovasc Surg. 2002 Apr;123(4):695-9. doi: 10.1067/mtc.2002.120712.
2
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.一项针对恶性胸膜间皮瘤的手术切除及辅助高剂量半胸放疗的II期试验。
J Thorac Cardiovasc Surg. 2001 Oct;122(4):788-95. doi: 10.1067/mtc.2001.116560.
3
Treatment of malignant mesothelioma.恶性间皮瘤的治疗
World J Surg. 2001 Feb;25(2):210-7. doi: 10.1007/s002680020021.
4
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.顺铂和吉西他滨治疗恶性间皮瘤:一项II期研究。
J Clin Oncol. 1999 Jan;17(1):25-30. doi: 10.1200/JCO.1999.17.1.25.
5
Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura.胸膜弥漫性恶性间皮瘤患者联合化疗的II期试验结果。
Cancer. 1999 Apr 15;85(8):1740-9.
6
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.切除边缘、胸膜外淋巴结状态和细胞类型决定恶性胸膜间皮瘤三联疗法的术后长期生存:183例患者的结果
J Thorac Cardiovasc Surg. 1999 Jan;117(1):54-63; discussion 63-5. doi: 10.1016/s0022-5223(99)70469-1.
7
Pharmacological basis for a novel therapeutic strategy based on the use of aquated cisplatin.基于水合顺铂使用的新型治疗策略的药理学基础。
Clin Cancer Res. 1997 Jul;3(7):1157-65.
8
Intraoperative intrapleural hypotonic cisplatin treatment for carcinomatous pleuritis.术中胸膜内注入低渗顺铂治疗癌性胸膜炎。
J Surg Oncol. 1997 Nov;66(3):196-200. doi: 10.1002/(sici)1096-9098(199711)66:3<196::aid-jso8>3.0.co;2-7.
9
Patterns of failure after trimodality therapy for malignant pleural mesothelioma.恶性胸膜间皮瘤三联疗法后的失败模式
Ann Thorac Surg. 1997 Feb;63(2):334-8. doi: 10.1016/s0003-4975(96)01228-3.
10
A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.国际间皮瘤兴趣小组提出的一种针对恶性胸膜间皮瘤的新国际TNM分期系统。
Lung Cancer. 1996 Feb;14(1):1-12. doi: 10.1016/0169-5002(95)00508-0.